Clinical Trial Update: L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating L-Arginine with or without enzyme inhibitors for erectile function in prostate cancer survivors; study completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Male Erectile Dysfunction
• Prostate Cancer
• Radiation Toxicity

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Male Erectile Disorder, Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-07-21